17/11/2026 EMVision Medical Devices Ltd ACN 620 388 230 Suite 4.01, 65 Epping Rd Sydney NSW 2113 02 8667 5337 contact@emvision.com.au EMV TO PRESENT AT THE BELL POTTER HEALTHCARE CONFERENCE 2026 EMVision Medical Devices Limited (ASX:EMV) (“EMVision” or the “Company”) is pleased to advise...
Bell Potter Healthcare Conference Presentation
Filed with ASX · · 27 pages · English
Summary by 6ix AI
EMVision Medical Devices Ltd. has announced that its CEO will present at the Bell Potter Healthcare Conference. The presentation will highlight key milestones for the company, including an upcoming pivotal trial readout.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
EMvision Medical Devices Ltd. on 6ix
In the deck
Story so far
Earlier from EMvision Medical Devices
- Quarterly Activities/Appendix 4C Cash Flow Report
- Notice of Annual General Meeting/Proxy Form
- Mayo Clinic emu Early Clinical Experience Presentation
- Date of AGM & Closing Date of Director Nominations
- $4.3m Non-Dilutive R&D Tax Rebate Received
Later from EMvision Medical Devices
All EMvision Medical Devices news releasesFollow EMvision Medical Devices into a list and get an email when it puts out news.
Follow EMvision Medical Devices